Psychedelic Spotlight News

Here’s How Many Billions of Dollars the Global Psychedelic Market May Be Worth by 2026

September 20, 2021June 2, 2024 Business, Learn

Recent analysis cites positive results of clinical psychedelic trials, coupled with a large amount of capital investment into biotech companies.

Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

September 17, 2021June 2, 2024 Learn, Uncategorized

“We are committed to leveraging this pledge as a powerful guide and resource to help us earn trust and to never lose sight of our ability to help contribute to the greater good of humanity,” says our CEO David Flores.

Psychedelic Business Spotlight: September 17, 2021

September 17, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across the Nordics.

United States’ First Actively Managed Psychedelics ETF Launches on NYSE Arca

September 16, 2021June 2, 2024 Business, Learn

PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier this year.

How 4 Indigenous Cultures Currently Use Psychedelics

September 16, 2021June 2, 2024 Culture, Learn

Explore how the Mazatecs, the Shipibo People, Yanomami People, and Africans practicing the Bwiti religion continue to use various entheogens to this day.

How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics

September 16, 2021June 2, 2024 Learn, Treatment

Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.